Galera Therapeutics, Inc. — 10-Q Filings
19 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Galera Therapeutics, Inc. (GRTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Galera Therapeutics, Inc. has filed 19 10-Q documents with the SEC since 2012. To view all SEC filings by Galera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-278816 | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-107616 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-071956 | May 15, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001193125-24-277849 | Dec 13, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-096654 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-058197 | May 13, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-063361 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-042058 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-020842 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-023516 | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-015753 | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009950 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003917 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-042885 | Aug 10, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-026290 | May 11, 2021 | Mar 31, 2021 |
| 10-Q | Q3 2020 10-Q | 0001564590-20-052739 | Nov 10, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-038606 | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-024495 | May 12, 2020 | Mar 31, 2020 |
| 10-Q | 10-Q | 0001564590-19-045585 | Dec 10, 2019 | Sep 30, 2019 |